TR201716235A2 - Pharmaceutical Composition Containing Multiple Active Ingredients for the Treatment of Respiratory Diseases - Google Patents
Pharmaceutical Composition Containing Multiple Active Ingredients for the Treatment of Respiratory Diseases Download PDFInfo
- Publication number
- TR201716235A2 TR201716235A2 TR2017/16235A TR201716235A TR201716235A2 TR 201716235 A2 TR201716235 A2 TR 201716235A2 TR 2017/16235 A TR2017/16235 A TR 2017/16235A TR 201716235 A TR201716235 A TR 201716235A TR 201716235 A2 TR201716235 A2 TR 201716235A2
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- pharmaceutical composition
- composition containing
- active ingredients
- containing multiple
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000023504 respiratory system disease Diseases 0.000 title 1
- BPZSYCZIITTYBL-YJYMSZOUSA-N R-Formoterol Chemical compound C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-YJYMSZOUSA-N 0.000 abstract 1
- 208000018569 Respiratory Tract disease Diseases 0.000 abstract 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 abstract 1
- 229960001692 arformoterol Drugs 0.000 abstract 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 abstract 1
- 229940092705 beclomethasone Drugs 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Mevcut buluş solunum yolları hastalıklarının tedavisinde kullanılacak arformoterol ve beklometazon ile antikolinerjikler grubundan seçilen uygun bir etken maddeyi içeren farmasötik bileşimlere ilişkindir.The present invention relates to pharmaceutical compositions containing arformoterol and beclomethasone to be used in the treatment of respiratory tract diseases and a suitable active ingredient selected from the group of anticholinergics.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/14725A TR201714725A1 (en) | 2017-09-30 | 2017-09-30 | DRY POWDER FORMULATION WITH BETA-2 AGONIST AND ANTICOLINERGIC |
| TR2017/14893A TR201714893A1 (en) | 2017-10-03 | 2017-10-03 | Dry powder composition containing Beta-2 Agonist and Corticosteroid. |
| TR2017/16203A TR201716203A1 (en) | 2017-10-20 | 2017-10-20 | New umeclidinium formulations. |
| TR2017/16233A TR201716233A2 (en) | 2017-09-30 | 2017-10-20 | Pharmaceutical composition containing multiple active ingredients for the treatment of respiratory diseases. |
| TR201716217 | 2017-10-20 | ||
| TR2017/16209A TR201716209A2 (en) | 2017-10-20 | 2017-10-20 | New pharmaceutical compositions containing arformoterol and umeclidinium. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201716235A2 true TR201716235A2 (en) | 2019-04-22 |
Family
ID=67900837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16235A TR201716235A2 (en) | 2017-09-30 | 2017-10-20 | Pharmaceutical Composition Containing Multiple Active Ingredients for the Treatment of Respiratory Diseases |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201716235A2 (en) |
-
2017
- 2017-10-20 TR TR2017/16235A patent/TR201716235A2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015160842A8 (en) | Methods and formulations of capsaicinoids and capsinoids | |
| MX2016010213A (en) | Novel pharmaceutical formulations. | |
| MX2022013612A (en) | Combinations of lsd1 inhibitors for the treatment of hematological malignancies. | |
| EA202090448A1 (en) | Dihydrooxadiazinones | |
| MX2021016109A (en) | Methods and compositions particularly for treatment of attention deficit disorder. | |
| EA201591541A1 (en) | BETA SECRETASE INHIBITORS 1 (BACE 1) | |
| MX2017004772A (en) | Compositions and methods for physiological delivery using cannabidiol. | |
| EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
| NZ718163A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| EA201690077A1 (en) | THERAPEUTICALLY ACTIVE DERIVATIVES OF ESTRATRIEN-THIAZOLE | |
| EA201991490A1 (en) | AROMATIC AMIDES OF CARBOXYLIC ACIDS AS BRAKININ B1 RECEPTOR ANTAGONISTS | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
| EA201892842A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID | |
| EA201890929A1 (en) | LOW DOSES OF DIPYRIDAMOL COMPOSITIONS FOR ORAL ADMINISTRATION AND THEIR USE | |
| PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy | |
| TR201716235A2 (en) | Pharmaceutical Composition Containing Multiple Active Ingredients for the Treatment of Respiratory Diseases | |
| PH12019500024A1 (en) | Pharmaceutical compositions | |
| EA202090666A1 (en) | APPLICATION OF BENZOATE-CONTAINING COMPOSITION FOR TREATMENT OF GLYCINE ENCEPHALOPATHY | |
| TR201716233A2 (en) | Pharmaceutical composition containing multiple active ingredients for the treatment of respiratory diseases. | |
| DOP2021000069A (en) | DERIVATIVES OF 4 PIRAZIN-2-ILMETIL-MORFOLINA AND THEIR USE AS A MEDICINAL PRODUCT | |
| WO2011093811A3 (en) | Pharmaceutical preparations comprising formoterol and fluticasone | |
| JOP20220045A1 (en) | Aqueous pharmaceutical composition of anti-pd1 antibody prolgolimab and use thereof | |
| PL431336A1 (en) | Lipopeptides, pharmaceutical composition, cosmetic composition, and lipopeptides for use as medicine | |
| TR201714726A1 (en) | Pharmaceutical formulation containing an anticholinergic active ingredient. | |
| EA202091127A1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING SAFINAMIDE |